Skip to main content
. 2012 Mar;56(3):1240–1246. doi: 10.1128/AAC.05485-11

Table 3.

Activities of pyrrolamide 4 and comparators against GyrB mutant strainsa of S. aureus

Compound S. aureus MIC (μg/ml)
Parent GyrB R144I GyrB T173A
Pyrrolamide 4 8 32 64
Novobiocin 0.25 8 0.25
Levofloxacin 0.25 0.25 0.25
a

Resistant strains of S. aureus were selected on media containing pyrrolamide 4 at 8 μg/ml. Point mutations in the gyrB genes were identified and mapped to the amino acids shown by sequencing genomic DNA isolated from different resistant strains.